All-Cause and Cause-Specific Mortality among Users of Basal Insulins NPH, Detemir, and Glargine

BACKGROUND: Insulin therapy in type 2 diabetes may increase mortality and cancer incidence, but the impact of different types of basal insulins on these endpoints is unclear. Compared to the traditional NPH insulin, the newer, longer-acting insulin analogues detemir and glargine have shown benefits...

Descripción completa

Detalles Bibliográficos
Autores principales: Strandberg, Arto Y., Hoti, Fabian J., Strandberg, Timo E., Christopher, Solomon, Haukka, Jari, Korhonen, Pasi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816506/
https://www.ncbi.nlm.nih.gov/pubmed/27031113
http://dx.doi.org/10.1371/journal.pone.0151910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4816506/
https://www.ncbi.nlm.nih.gov/pubmed/27031113
http://dx.doi.org/10.1371/journal.pone.0151910

Ejemplares similares